Aubrey de Grey Keynote Speaker

Chief Science Officer, SENS Research Foundation (2009-present)
Famous for claiming that ageing is a curable disease
Author of controversial, internationally best-selling books on life extension

Aubrey de Grey's Biography

Dr Aubrey de Grey is a biomedical gerontologist based in Mountain View, California, USA.

He served as Chief Science Officer of the SENS Research Foundation (2009–2021), a California-based 501(c)(3) biomedical research charity that performs and funds laboratory research dedicated to combating the aging process.

He was Editor-in-Chief of Rejuvenation Research (2004–2022), the world’s highest-impact peer-reviewed journal focused on intervention in aging, and was VP of New Technology Discovery at AgeX Therapeutics, a biotechnology startup developing new therapies in the field of biomedical gerontology.

His research interests encompass the characterisation of all the types of self-inflicted cellular and molecular damage that constitute mammalian aging and the design of interventions to repair and/or obviate that damage.

Dr. de Grey is a Fellow of both the Gerontological Society of America and the American Aging Association, and sits on the editorial and scientific advisory boards of numerous journals and organisations. He is a highly sought-after speaker who gives 40-50 invited talks per year at scientific conferences, universities, companies in areas ranging from pharma to life insurance, and to the public.

He received his BA in computer science and PhD in biology from the University of Cambridge.

He is a pioneering biomedical gerontologist focused on understanding and repairing the cellular damage that drives human aging.
He has led influential research initiatives to develop therapies aimed at preventing age-related disease and extending healthy lifespan.
He bridges cutting-edge longevity science with the practical implications for healthcare, biotechnology and society.
His talks challenge audiences to rethink aging as a solvable medical problem rather than an inevitable process.
He delivers clear, provocative insights on the future of longevity, medicine and the economics of longer lives.